Medserve Diagnostic Services Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-07-2024
- Paid Up Capital ₹ 0.10 M
as on 15-07-2024
- Company Age 29 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2016)
- Ebitda
- Net Worth -51.83%
(FY 2016)
- Total Assets %
(FY 2016)
About Medserve Diagnostic Services
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kuttapalayam Songappan and Jansi Ramalingam serve as directors at the Company.
- CIN/LLPIN
U85195TZ1995PTC006202
- Company No.
006202
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jun 1995
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Medserve Diagnostic Services?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kuttapalayam Songappan  | Director | 13-Jun-1995 | Current |
| Jansi Ramalingam | Director | 13-Jun-1995 | Current |
Financial Performance and Corporate Structure Insights of Medserve Diagnostic Services.
Medserve Diagnostic Services Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 51.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Medserve Diagnostic Services?
In 2017, Medserve Diagnostic Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Lotus Eye Hospital And Institute LimitedActive 27 years 9 monthsKuttapalayam Songappan is a mutual person
Coimbatore Kidney Care And Research LimitedActive 34 years 6 monthsKuttapalayam Songappan and Jansi Ramalingam are mutual person
Coimbatore Healthcare Investors Private LimitedActive 2 years 10 monthsKuttapalayam Songappan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medserve Diagnostic Services?
Unlock and access historical data on people associated with Medserve Diagnostic Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medserve Diagnostic Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medserve Diagnostic Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
